-
Global Alzheimer’s Platform Foundation Statement on Biogen’s Submission of Aducanumab Application to the FDA Posted on by Taylor Disselhorst in Press Releases
-
How Alzheimer’s Clinical Trials Have Become COVID-19 Victims Posted on by Taylor Disselhorst in In the News
-
Alzheimer’s Research Needs Your Help Posted on by Taylor Disselhorst in Featured
-
Alzheimer’s Researchers Fight Delays Caused by COVID-19 Posted on by Taylor Disselhorst in Featured&In the News
-
In the Wake of COVID-19: Trials Interrupted, Delayed, Cancelled Posted on by Taylor Disselhorst in Featured&In the News
-
Critical Medical Research Put on Hold Amid Pandemic Posted on by Taylor Disselhorst in In the News&Network
-
Clinical Trials Press Forward in Age of COVID Posted on by Taylor Disselhorst in In the News
-
Improv Improves How Caregivers Work with Patients Posted on by Taylor Disselhorst in In the News
-
GAP Statement on Racial Inequality Posted on by Taylor Disselhorst in Featured&Press Releases
-
Guest Column: Another Growing Health Crisis Posted on by Taylor Disselhorst in In the News
